Yan-Ruide Li
Impact in
- Oncology top 5%
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
- Immunology top 10%
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
- Immunotherapy and Immune Responses
- Immune cells in cancer
Papers in
- Oncology 42
- CAR-T cell therapy research 41
- Cancer Immunotherapy and Biomarkers 4
- Immunology 30
- Immune Cell Function and Interaction 28
- T-cell and B-cell Immunology 12
- Co-authors
- Lili Yang (35 shared papers)Ying Fang (15 shared papers)Yichen Zhu (14 shared papers)Yang Zhou (10 shared papers)Matthew Wilson (7 shared papers)Adam B. Kramer (8 shared papers)Zachary Spencer Dunn (7 shared papers)Yanqi Yu (5 shared papers)
- Journals
- Nature Communications (3 papers)Trends in cancer (3 papers)Trends in Pharmacological Sciences (2 papers)Cancers (2 papers)Journal of Translational Medicine (2 papers)
- Partner nations
- United StatesRussia
In The Last Decade
Yan-Ruide Li
47 papers receiving 878 citations
Yan-Ruide Li's Hit Papers
Peers
Comparison fields: 5 of 71
- Oncology 586
- Immunology 399
- Biological Psychiatry 10
- Biomedical Engineering 159
- Molecular Biology 249
Countries citing papers authored by Yan-Ruide Li
This map shows the geographic impact of Yan-Ruide Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yan-Ruide Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yan-Ruide Li more than expected).
Fields of papers citing papers by Yan-Ruide Li
This network shows the impact of papers produced by Yan-Ruide Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yan-Ruide Li. The network helps show where Yan-Ruide Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Yan-Ruide Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 51 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 120 | |
| 2 | 2023 | 76 | |
| 3 | 2022 | 48 | |
| 4 | 2023 | 48 | |
| 5 | 2022 | 45 | |
| 6 | 2023 | 41 | |
| 7 | 2024 | 40 | |
| 8 | 2024 | 33 | |
| 9 | 2022 | 33 | |
| 10 | 2021 | 27 | |
| 11 | 2022 | 26 | |
| 12 | 2021 | 25 | |
| 13 | 2023 | 23 | |
| 14 | Allogeneic CD33-directed CAR-NKT cells for the treatment of bone marrow-resident myeloid malignancies Hit paper breakdown → | 2025 | 23 |
| 15 | 2022 | 23 | |
| 16 | 2024 | 22 | |
| 17 | In vivo CAR engineering for immunotherapy Hit paper breakdown → | 2025 | 20 |
| 18 | 2022 | 16 | |
| 19 | 2025 | 16 | |
| 20 | 2024 | 16 |
About Yan-Ruide Li
Yan-Ruide Li is a scholar working on Oncology, Immunology, Molecular Biology, Biomedical Engineering and Genetics, having authored 51 papers that have together received 888 indexed citations. Recurring topics across this work include CAR-T cell therapy research (41 papers), Immune Cell Function and Interaction (28 papers), T-cell and B-cell Immunology (12 papers), Virus-based gene therapy research (6 papers), Nanowire Synthesis and Applications (5 papers), Viral Infectious Diseases and Gene Expression in Insects (5 papers), CRISPR and Genetic Engineering (4 papers) and Cancer Immunotherapy and Biomarkers (4 papers). The work is most often cited by research in Oncology (586 citations), Immunology (399 citations), Biological Psychiatry (10 citations), Biomedical Engineering (159 citations) and Molecular Biology (249 citations). Yan-Ruide Li has collaborated with scholars based in United States and Russia. Frequent co-authors include Lili Yang, Ying Fang, Yichen Zhu, Yang Zhou, Matthew Wilson, Adam B. Kramer, Zachary Spencer Dunn, Yanqi Yu, Kuangyi Zhou and Jiaji Yu. Their work appears in journals such as Nature Communications, Trends in cancer, Trends in Pharmacological Sciences, Cancers and Journal of Translational Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.